Literature DB >> 23294666

Incident hypertension in older women and men with or at risk for HIV infection.

S H Factor1, Y Lo, E Schoenbaum, R S Klein.   

Abstract

OBJECTIVES: Antiretroviral (ARV) therapy has prolonged the life expectancy of HIV-infected persons, increasing their risk of age-associated diseases, including atherosclerosis (AS). Decreased risk of AS has been associated with the prevention and control of hypertension (HTN). We conducted a cohort study of perimenopausal women and older men with or at risk of HIV infection to identify risk factors for incident HTN.
METHODS: Standardized interviews, physical examinations, and laboratory examinations were scheduled at 6-month intervals. Interview data included demographics, medical, family, sexual behaviour and drug use histories, and physical activity.
RESULTS: There were 330 women and 329 men eligible for inclusion in the study; 27% and 35% of participants developed HTN during a median follow-up period of 1080 and 1071 days, respectively. In gender-stratified analysis, adjusting for traditional HTN risk factors (age, race, body mass index, smoking, diabetes, family history of HTN, alcohol dependence, physical activity and high cholesterol), HIV infection was not associated with incident HTN in women [hazard ratio (HR) 1.31; 95% confidence interval (CI) 0.56, 3.06] or men (HR 1.67; 95% CI 0.75, 3.74). Among HIV-infected women, although exposure to ARVs was not significantly associated with incident HTN (HR 0.72; 95% CI 0.26, 1.99), CD4 T-cell count was positively associated with incident HTN (HR 1.15 per 100 cells/μL; 95% CI 1.03, 1.28). Among physically active HIV-infected men, exposure to ARVs was negatively associated with incident HTN (HR 0.15; 95% CI 0.03, 0.78).
CONCLUSIONS: HIV infection was not associated with incident HTN in older men or women. This study provides additional evidence supporting a causal relationship between immune function and incident HTN, which warrants further study.
© 2013 British HIV Association.

Entities:  

Mesh:

Year:  2013        PMID: 23294666      PMCID: PMC4572696          DOI: 10.1111/hiv.12010

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  31 in total

1.  Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.

Authors:  Jacqueline Neuhaus; David R Jacobs; Jason V Baker; Alexandra Calmy; Daniel Duprez; Alberto La Rosa; Lewis H Kuller; Sarah L Pett; Matti Ristola; Michael J Ross; Michael G Shlipak; Russell Tracy; James D Neaton
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection.

Authors:  Jennifer L Lyons; Hajime Uno; Petronela Ancuta; Anupa Kamat; David J Moore; Elyse J Singer; Susan Morgello; Dana Gabuzda
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

Review 3.  Exercise-induced myokines and their role in chronic diseases.

Authors:  Bente K Pedersen
Journal:  Brain Behav Immun       Date:  2011-02-25       Impact factor: 7.217

4.  Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Authors:  Phyllis C Tien; Andy I Choi; Andrew R Zolopa; Constance Benson; Russell Tracy; Rebecca Scherzer; Peter Bacchetti; Michael Shlipak; Carl Grunfeld
Journal:  J Acquir Immune Defic Syndr       Date:  2010-11       Impact factor: 3.731

5.  Markers of atherosclerosis and inflammation and mortality in patients with HIV infection.

Authors:  Alexandra Mangili; Joseph F Polak; Lien A Quach; Jul Gerrior; Christine A Wanke
Journal:  Atherosclerosis       Date:  2010-11-17       Impact factor: 5.162

6.  Plasma levels of soluble CD14 independently predict mortality in HIV infection.

Authors:  Netanya G Sandler; Handan Wand; Annelys Roque; Matthew Law; Martha C Nason; Daniel E Nixon; Court Pedersen; Kiat Ruxrungtham; Sharon R Lewin; Sean Emery; James D Neaton; Jason M Brenchley; Steven G Deeks; Irini Sereti; Daniel C Douek
Journal:  J Infect Dis       Date:  2011-01-20       Impact factor: 5.226

7.  Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006.

Authors:  William K Adih; Richard M Selik; Xiaohong Hu
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2010-11-18

8.  Factors associated with accelerated atherosclerosis in HIV-1-infected persons treated with protease inhibitors.

Authors:  Shenghan Lai; Hong Lai; David D Celentano; David Vlahov; Shiquan Ren; Joseph Margolick; Joao A C Lima; John G Bartlett
Journal:  AIDS Patient Care STDS       Date:  2003-05       Impact factor: 5.078

9.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

10.  T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women.

Authors:  Robert C Kaplan; Elizabeth Sinclair; Alan L Landay; Nell Lurain; A Richey Sharrett; Stephen J Gange; Xiaonan Xue; Peter Hunt; Roksana Karim; David M Kern; Howard N Hodis; Steven G Deeks
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

View more
  5 in total

1.  Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.

Authors:  Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

Review 2.  Sex differences in T cells in hypertension.

Authors:  Ashlee J Tipton; Jennifer C Sullivan
Journal:  Clin Ther       Date:  2014-08-16       Impact factor: 3.393

3.  First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000-2013.

Authors:  Cherise Wong; Stephen J Gange; Kate Buchacz; Richard D Moore; Amy C Justice; Michael A Horberg; M John Gill; John R Koethe; Peter F Rebeiro; Michael J Silverberg; Frank J Palella; Pragna Patel; Mari M Kitahata; Heidi M Crane; Alison G Abraham; Hasina Samji; Sonia Napravnik; Tareq Ahmed; Jennifer E Thorne; Ronald J Bosch; Angel M Mayor; Keri N Althoff
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

4.  Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia.

Authors:  Nazisa Hejazi; M S L Huang; Khor Geok Lin; Lee Christopher Kwok Choong
Journal:  Glob J Health Sci       Date:  2013-12-01

5.  Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia.

Authors:  Zerihun Ataro; Wondimye Ashenafi; Jiregna Fayera; Tekabe Abdosh
Journal:  HIV AIDS (Auckl)       Date:  2018-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.